Ultimovacs AB
559144-3162ActivePioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Overview
- 0
- Employees
- 5–10M SEK
- Revenue
- 2018
- Founded
Key Decision Makers
Namir Hassan
CEO
Description
Zelluna is a biotechnology company dedicated to pioneering novel cell therapies for the treatment of cancer patients. Their core mission is to eliminate solid cancers by developing T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This proprietary platform aims to ove...
Tags
Keywords
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559144316201
Decision Makers
1 contacts in FunnelfeedrNamir Hassan
CEO
Similar Companies
20 similar companies in Funnelfeedr
ZELLUNA IMMUNOTHERAPY AS
9 employeesPioneering TCR-NK cell therapies to eliminate solid cancers safely.
ZELLUNA ASA
8 employeesPioneering TCR-NK cell therapies to eliminate solid cancers effectively.
CuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
CANTARGIA AB
20–49 employeesDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Browse More
Ultimovacs AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo